Ident. | Authors (with country if any) | Title |
---|
000121 |
Akram Aminjafari [Iran] ; Sorayya Ghasemi [Iran] | The possible of immunotherapy for COVID-19: A systematic review. |
000220 |
Shima T. Moein [Iran] ; Seyed M R. Hashemian [Iran] ; Babak Mansourafshar [Iran] ; Ali Khorram-Tousi [Iran] ; Payam Tabarsi [Iran] ; Richard L. Doty [États-Unis] | Smell dysfunction: a biomarker for COVID-19. |
000291 |
Latif Panahi [Iran] ; Marzieh Amiri [Iran] ; Somaye Pouy [Iran] | Risks of Novel Coronavirus Disease (COVID-19) in Pregnancy; a Narrative Review |
000357 |
Parisa Ghelichkhani [Iran] ; Maryam Esmaeili [Iran] | Prone Position in Management of COVID-19 Patients; a Commentary. |
000369 |
Amir Emami [Iran] ; Fatemeh Javanmardi [Iran] ; Neda Pirbonyeh [Iran] ; Ali Akbari [Iran] | Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis |
000387 |
Farid Rahimi [Australie] ; Amin Talebi Bezmin Abadi [Iran] | Practical Strategies Against the Novel Coronavirus and COVID-19-the Imminent Global Threat. |
000395 |
Ali Rismanbaf [Iran] | Potential Treatments for COVID-19; a Narrative Literature Review. |
000447 |
Sepideh Paybast [Iran] ; Ali Emami [Iran] ; Mohsen Koosha [Iran] ; Fatemeh Baghalha [Iran] | Novel Coronavirus Disease (COVID-19) and Central Nervous System Complications: What Neurologist Need to Know. |
000466 |
Parisa Karami [Iran] ; Maliheh Naghavi [Iran] ; Abdolamir Feyzi [Iran] ; Mehdi Aghamohammadi [Iran] ; Mohammad Sadegh Novin [Iran] ; Ahmadreza Mobaien [Iran] ; Mohamad Qorbanisani [Iran] ; Aida Karami [Iran] ; Amir Hossein Norooznezhad [Iran] | Mortality of a pregnant patient diagnosed with COVID-19: A case report with clinical, radiological, and histopathological findings |
000500 |
Ali Asadollahi-Amin [Iran] ; Mehrdad Hasibi [Iran] ; Fatemeh Ghadimi [Iran] ; Hosnieh Rezaei [Iran] ; Seyedahmad Seyedalinaghi [Iran] | Lung Involvement Found on Chest CT Scan in a Pre-Symptomatic Person with SARS-CoV-2 Infection: A Case Report. |
000521 |
Maryam Fattahian [Iran] ; Mustafa Ghanadian [Iran] ; Zulfiqar Ali [États-Unis] ; Ikhlas A. Khan [États-Unis] | Jatrophane and rearranged jatrophane-type diterpenes: biogenesis, structure, isolation, biological activity and SARs (1984-2019). |
000552 |
Amin Gasmi [France] ; Sadaf Noor [Pakistan] ; Torsak Tippairote [Thaïlande] ; Maryam Dadar [Iran] ; Alain Menzel [France] ; Geir Bj Rklund [Norvège] | Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic |
000568 |
Mohsen Rokni [Iran] ; Vida Ghasemi [Iran] ; Zahra Tavakoli [Iran] | Immune responses and pathogenesis of SARS-CoV-2 during an outbreak in Iran: Comparison with SARS and MERS. |
000608 |
Leila Mousavizadeh [Allemagne] ; Sorayya Ghasemi [Iran] | Genotype and phenotype of COVID-19: Their roles in pathogenesis |
000678 |
Yashpal Singh Malik [Inde] ; Shubhankar Sircar [Inde] ; Sudipta Bhat [Inde] ; Khan Sharun [Inde] ; Kuldeep Dhama [Inde] ; Maryam Dadar [Iran] ; Ruchi Tiwari [Inde] ; Wanpen Chaicumpa [Thaïlande] | Emerging novel coronavirus (2019-nCoV)—current scenario, evolutionary perspective based on genome analysis and recent developments |
000714 |
Azar Hadadi [Iran] ; Masoud Mortezazadeh [Iran] ; Kasra Kolahdouzan [Iran] ; Golbarg Alavian [Iran] | Does recombinant human Erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects? |
000750 |
Morteza Abdullatif Khafaie [Iran] ; Fakher Rahim [Iran] | Cross-Country Comparison of Case Fatality Rates of COVID-19/SARS-COV-2 |
000818 |
Zohre Khodamoradi [Iran] ; Mohsen Moghadami [Iran] ; Mehrzad Lotfi [Iran] | Co-infection of Coronavirus Disease 2019 and Influenza A: A Report from Iran. |
000863 |
Ali A. Asadi-Pooya [Iran, États-Unis] ; Leila Simani [Iran] | Central nervous system manifestations of COVID-19: A systematic review |
000904 |
Kuldeep Dhama [Inde] ; Khan Sharun [Inde] ; Ruchi Tiwari [Inde] ; Maryam Dadar [Iran] ; Yashpal Singh Malik [Inde] ; Karam Pal Singh [Inde] ; Wanpen Chaicumpa [Thaïlande] | COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics |
000986 |
Mahmoud Yousefifard [Iran] ; Alireza Zali [Iran] ; Kosar Mohamed Ali [Iraq] ; Arian Madani Neishaboori [Iran] ; Afshin Zarghi [Iran] ; Mostafa Hosseini [Iran] ; Saeed Safari [Iran] | Antiviral therapy in management of COVID-19: a systematic review on current evidence |
000A37 |
Sasan Faridi [Iran] ; Sadegh Niazi [Australie] ; Kaveh Sadeghi ; Kazem Naddafi [Iran] ; Jila Yavarian ; Mansour Shamsipour [Iran] ; Nazanin Zahra Shafiei Jandaghi ; Khosro Sadeghniiat [Iran] ; Ramin Nabizadeh [Iran] ; Masud Yunesian [Iran] ; Fatemeh Momeniha [Iran] ; Adel Mokamel [Iran] ; Mohammad Sadegh Hassanvand [Iran] ; Talat Mokhtariazad [Iran] | A field indoor air measurement of SARS-CoV-2 in the patient rooms of the largest hospital in Iran. |
000B06 |
Hadis Fathizadeh ; Parham Maroufi [Iran] ; Mansooreh Momen-Heravi [Iran] ; Sounkalo Dao [Mali] ; Kran Köse [Turquie] ; Khudaverdi Ganbarov ; Pasquale Pagliano [Italie] ; Silvano Esposito [Italie] ; Hossein Samadi Kafil [Iran] | Protection and disinfection policies against SARS-CoV-2 (COVID-19). |
000B14 |
Mahdi Asghari Ozma [Iran] ; Parham Maroufi [Iran] ; Ehsaneh Khodadadi [Iran] ; Kran Köse [Turquie] ; Isabella Esposito [Italie] ; Khudaverdi Ganbarov ; Sounkalo Dao [Mali] ; Silvano Esposito [Italie] ; Tuba Dal [Turquie] ; Elham Zeinalzadeh [Iran] ; Hossein Samadi Kafil [Iran] | Clinical manifestation, diagnosis, prevention and control of SARS-CoV-2 (COVID-19) during the outbreak period. |